(Q37225923)

19 August 2017

1 reference

title

Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions (English)

1 reference

19 August 2017

0 references

1 reference

Benedicto Crespo-Facorro

1

object named as

Benedicto Crespo-Facorro

0 references

author name string

Rocío Pérez-Iglesias

2

1 reference

19 August 2017

Cesar González-Blanch

3

1 reference

19 August 2017

Ignacio Mata

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Current Psychiatry Reports

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

3

1 reference

19 August 2017

202-209

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-008-0034-1

19 August 2017

0 references

cites work

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-008-0034-1

Olanzapine versus haloperidol treatment in first-episode psychosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-008-0034-1

Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-008-0034-1

Family work in first-onset psychosis: a literature review.

21 January 2018

1 reference

12 December 2020

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

1 reference

12 December 2020

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.

1 reference

12 December 2020

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

12 December 2020

Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing

1 reference

12 December 2020

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

1 reference

12 December 2020

Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication

1 reference

12 December 2020

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy.

1 reference

12 December 2020

Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention

1 reference

12 December 2020

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

1 reference

12 December 2020

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

12 December 2020

Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project

1 reference

12 December 2020

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

1 reference

12 December 2020

Psychosocial treatment for first-episode psychosis: a research update

1 reference

12 December 2020

A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis

1 reference

12 December 2020

Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

1 reference

12 December 2020

A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data

1 reference

12 December 2020

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

1 reference

12 December 2020

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

1 reference

12 December 2020

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

1 reference

12 December 2020

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

12 December 2020

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

1 reference

12 December 2020

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

1 reference

12 December 2020

Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory

1 reference

12 December 2020

Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.

1 reference

12 December 2020

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

12 December 2020

Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.

1 reference

12 December 2020

Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis

1 reference

12 December 2020

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

1 reference

12 December 2020

Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

1 reference

12 December 2020

Olanzapine and haloperidol in first episode psychosis: two-year data

1 reference

12 December 2020

Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.

1 reference

12 December 2020

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

12 December 2020

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

1 reference

12 December 2020

Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders

1 reference

12 December 2020

Integrating non-drug treatments in early schizophrenia

1 reference

12 December 2020

Pharmacogenetic prediction of clozapine response

1 reference

12 December 2020

Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.

1 reference

12 December 2020

Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain.

1 reference

12 December 2020

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

1 reference

12 December 2020

Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis.

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

1 reference

12 December 2020

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population

1 reference

12 December 2020

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

12 December 2020

Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients. An 18-month study in Suzhou, Jiangsu

1 reference

12 December 2020

10.1007/S11920-008-0034-1

Identifiers

DOI

1 reference

19 August 2017

1 reference